Astera Labs vs. Arm: Which Semiconductor Stock Is a Better Buy in 2026?

Astera Labs is favored over Arm for 2026 based on AI-data-center connectivity demand, with fiscal 2025 revenue rising 115.1% to $852.5 million and full-year growth guidance above 85%. Arm delivered steadier scale, reporting fiscal 2026 revenue of $4.9 billion, up 22.8%, and $904.0 million in net income, but trades at a higher 131.1x forward P/E versus Astera's 89.4x. Key Astera risks are severe customer concentration—86% of sales from three customers—and exposure to TSMC-linked geopolitical and supply-chain risks.

Analysis

The relevant distinction is not AI exposure but position in the bill of materials. ALAB monetizes incremental rack complexity, making its revenue highly sensitive to GPU-cluster build cadence and architectural transitions (PCIe/CXL generations); that creates upside torque if hyperscalers continue moving toward disaggregated, scale-up fabrics. It also makes earnings vulnerable to a single customer's qualification change or a pause in one platform ramp, with excess inventory likely appearing first at distributors and foundry-linked supply chains rather than in reported revenue. AVGO and MRVL are more diversified substitutes/adjacencies: an AI-connectivity spend slowdown would likely compress ALAB's multiple disproportionately, but neither incumbent necessarily captures its lost sockets without a design-win catalyst.

ARM is structurally less exposed to a single AI capex cycle, but its valuation requires sustained royalty mix improvement from higher-value compute and continued server-CPU share gains. The non-obvious risk is that hyperscaler custom silicon can be both a royalty tailwind and a bargaining-power headwind: greater Arm-based unit volume does not guarantee proportionate royalty economics if large customers negotiate architecture licenses or shift marginal workloads toward RISC-V. Over the next 1-3 months, quarterly guidance, customer concentration disclosures, and evidence of CXL attach-rate expansion matter more than broad AI sentiment; over 6-18 months, the key question is whether connectivity content per AI rack rises fast enough to offset eventual price competition from AVGO/MRVL.

Consensus appears to frame ALAB as a cheaper version of ARM. That is misleading: both trade as long-duration execution assets, but ALAB deserves a materially wider valuation band because a revenue-concentration shock can reset estimates in one quarter, while ARM's risk is slower-moving multiple compression. The better relative expression is to own ALAB only against a hedge in diversified connectivity exposure, rather than treating it as a standalone core AI holding.

Key Decisions for Investors

• Initiate a 1-3 month small long ALAB / short MRVL pair only after ALAB reaffirms full-year growth and discloses no deterioration in its largest-customer demand. Target 15-20% relative upside if AI rack deployments remain capacity constrained; exit if ALAB cuts guidance, reports material receivables/inventory growth, or loses a next-generation platform qualification.
• Maintain ARM as a watchlist long rather than chase exposure before the next results. Upgrade to a 6-12 month position only if data-center royalty growth and royalty revenue per chip demonstrate that server mix is offsetting mobile cyclicality; a deceleration in royalty growth or evidence of licensing-price pressure would support a short/underweight despite favorable unit volumes.
• For AI-connectivity exposure, prefer a barbell of long ALAB and long AVGO over a concentrated ALAB position, sized roughly 1:2 by dollar risk. AVGO provides downside resilience through broader networking/custom-silicon exposure while retaining upside if hyperscaler capex broadens; reassess if AI networking order commentary weakens across both companies.
• Set an earnings-season alert around hyperscaler capex guidance and TSM advanced-node commentary. A broad capex reduction or lead-time normalization is the clearest near-term falsifier for ALAB's operating leverage thesis and would warrant reducing high-multiple semiconductor exposure before revisions propagate.